Pitch opportunity: Accelerate your Innovation to business!

Hosted by Johnson & Johnson Innovation

Young companies active in the life sciences industry, pitch your company and/or innovations at the Dutch Life Sciences conference. Increase your visibility, earn PR and connect to collaboration partners and investors.

The Investors forum is an exciting opportunity for young life sciences companies that have not reach the series A financing stage and looking for equity capital and/or partnerships. The forum offers excellent opportunities for presenting your company to Venture Capitalists, corporate- and regional investment funds and discuss your business strategy.

Participate in the Investors Forum and grab your chance to meet with interesting partners, initiate strategic alliances or tap into the international financing networks.

The winner of the Investors Forum will be awarded the ´Investors Forum prize´, a partnering ticket with a total value of EUR 2,500 and will be allowed to repeat the winning pitch in the plenary program. 

All selected pitching parties will be invited to the VIP speakers- and partner dinner the evening prior to the conference.

Who can apply?
Young Life Sciences companies that have not reach the series A financing stage and looking for equity capital and/or partnerships are invited to participate.

Selection
Participation will be reviewed by the program committee. The candidates have to perform a test pitch which will be part of the selection procedure which will take place in week 44 (dates to be announced). Your participation in the Investors Forum will be definite after receiving your personal confirmation to pitch.

Participating investors 
The Investors Forum enables you to evaluate new investment opportunities and to meet with the management of the most promising life sciences companies, start-ups as well as established ventures. After the forum there will be ample opportunity to further discuss future collaborations in one-on-one meetings.

Overview of investors present (in 2025):

• Brabantse Ontwikkelings Maatschappij
• Curie Capital
• FIRST fund at BGV (BioGeneration Ventures)
  
• Flanders Investment & Trade
• Forbion
• Heran Partners
• Inkef
• Invest-NL
• Oost NL
• ROM InWest
• ROM Utrecht Region
• Thuja Capital
• Utrecht Holdings Seed Fund 
• XGEN Venture

The jury consists of:

• Lisanne Blauw,  Associate Thuja Capital (chair)
• Thom Frielink, Sr. Associate Curie Capital
• Viggo van Tendeloo, Director, Early-stage Innovation Benelux J&J Innovative Medicine
  
  

General information and registration 
During the conference the forum will be held in two sessions:

• Part 1 - breakfast session (08:00 - 09:00)
• Part 2 - lunch session (13:00 - 14:00)

This will enable participants to attend the complete program of the conference as well. Participation in the Investors Forum involves no additional costs. Conference registration is all that is required.

The Investors Forum may be sold out.